Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2022-09-15 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
董事会有关本次发行并上市的决议
Board/Management Information Classification · 95% confidence The document is a resolution from the first board of directors' ninth meeting of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It details decisions related to the company's initial public offering (IPO) of A shares on the Shenzhen Stock Exchange's ChiNext board. The content includes approval of the issuance type, number of shares, pricing, underwriting, investment projects for raised funds, and authorization for the board to handle IPO-related matters. The document is a formal board meeting resolution, not a full financial report or earnings release. It is not a shareholder meeting material or voting result announcement but rather a management/board decision document. Therefore, it fits best under Board/Management Information (MANG). The document length is 4192 characters, which is consistent with a detailed board resolution but not a full annual or interim report.
2022-09-15 Chinese
广东信达律师事务所关于公司首次公开发行人民币普通股股票并在创业板上市之补充法律意见书（一）
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter related to the initial public offering (IPO) and listing of Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. on the Shenzhen Stock Exchange's Growth Enterprise Market. It includes extensive legal and financial disclosures, audit references, shareholder and management information, and compliance with regulatory requirements. The document is not a financial report like an annual or interim report, nor is it a simple announcement. It is a legal opinion supplement related to the IPO process, focusing on legal compliance, shareholder structure, and related party transactions. This type of document fits best under the category of Regulatory Filings (RNS), as it is a regulatory compliance document that does not fit into other specific categories such as Annual Report, Audit Report, or Capital/Financing Update. The document length (15,000 characters) and content confirm it is a substantive filing, not a brief announcement or certification.
2022-09-15 Chinese
审阅报告
Regulatory Filings
2022-09-15 Chinese
首次公开发行股票并在创业板上市招股意向书
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus (招股意向书) for an initial public offering (IPO) of Shenzhen Mehow Innovative Ltd. on the Shenzhen Stock Exchange's Growth Enterprise Market (创业板). It includes extensive information about the stock issuance, risk factors, financial data, management commitments, and other disclosures typical of an IPO prospectus. The document is not a simple announcement but a comprehensive filing with financial data, risk disclosures, governance, and business details. This type of document corresponds to a Capital/Financing Update (CAP) as it relates to the company's fundraising and capital structure changes through a public offering. It is not an Annual Report, Earnings Release, or other categories. The length and content confirm it is a full prospectus rather than a brief announcement or regulatory filing.
2022-09-15 Chinese
财务报表及审计报告
Regulatory Filings
2022-09-15 Chinese
广东信达律师事务所关于公司首次公开发行人民币普通股股票并在创业板上市之补充法律意见书（六）
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from Guangdong Xinda Law Firm regarding Shenzhen Mehao Chuangyi Medical Technology Co., Ltd.'s initial public offering (IPO) of RMB ordinary shares and listing on the ChiNext board of the Shenzhen Stock Exchange. It includes extensive legal verification, governance structure explanations, shareholder relationships, income recognition policies, and risk disclosures related to the IPO process. The document references the IPO, listing, and related regulatory review letters, and is a supplementary legal opinion (Supplementary Legal Opinion No. 6). It is not a financial report, earnings release, or management discussion, but a legal opinion supporting the IPO filing. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory compliance/legal document related to the IPO process and does not fit other categories such as Annual Report, Audit Report, or Capital Update. The document length is substantial and contains detailed legal content, not merely an announcement or certification, so it is not RPA or a certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-09-15 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.